Emergent BioSolutions, Inc. (EBS)
5.50
-0.11
(-1.96%)
USD |
NYSE |
Nov 18, 16:00
5.93
+0.43
(+7.82%)
Pre-Market: 08:10
Emergent BioSolutions Max Drawdown (5Y) : 98.89% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 98.89% |
| September 30, 2026 | 98.89% |
| August 31, 2026 | 98.89% |
| July 31, 2026 | 98.89% |
| June 30, 2026 | 98.89% |
| May 31, 2026 | 98.89% |
| April 30, 2026 | 98.89% |
| March 31, 2026 | 98.89% |
| February 28, 2026 | 98.89% |
| January 31, 2026 | 98.89% |
| December 31, 2025 | 98.89% |
| November 30, 2025 | 98.89% |
| October 31, 2025 | 98.89% |
| September 30, 2025 | 98.89% |
| August 31, 2025 | 98.89% |
| July 31, 2025 | 98.89% |
| June 30, 2025 | 98.89% |
| May 31, 2025 | 98.89% |
| April 30, 2025 | 98.89% |
| March 31, 2025 | 98.89% |
| February 28, 2025 | 98.89% |
| January 31, 2025 | 98.89% |
| December 31, 2024 | 98.89% |
| November 30, 2024 | 98.89% |
| October 31, 2024 | 98.89% |
| Date | Value |
|---|---|
| September 30, 2024 | 98.89% |
| August 31, 2024 | 98.89% |
| July 31, 2024 | 98.89% |
| June 30, 2024 | 98.89% |
| May 31, 2024 | 98.89% |
| April 30, 2024 | 98.89% |
| March 31, 2024 | 98.89% |
| February 29, 2024 | 98.89% |
| January 31, 2024 | 98.76% |
| December 31, 2023 | 98.65% |
| November 30, 2023 | 98.65% |
| October 31, 2023 | 98.52% |
| September 30, 2023 | 97.65% |
| August 31, 2023 | 96.98% |
| July 31, 2023 | 94.98% |
| June 30, 2023 | 94.55% |
| May 31, 2023 | 94.23% |
| April 30, 2023 | 94.23% |
| March 31, 2023 | 94.23% |
| February 28, 2023 | 91.85% |
| January 31, 2023 | 91.85% |
| December 31, 2022 | 91.85% |
| November 30, 2022 | 91.40% |
| October 31, 2022 | 86.53% |
| September 30, 2022 | 85.11% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Vertex Pharmaceuticals, Inc. | 40.15% |
| Arcturus Therapeutics Holdings, Inc. | 95.23% |
| Capricor Therapeutics, Inc. | 91.80% |
| Travere Therapeutics, Inc. | 83.44% |
| Syndax Pharmaceuticals, Inc. | 69.88% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -55.55 |
| Beta (5Y) | 2.370 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 106.2% |
| Historical Sharpe Ratio (5Y) | -0.3398 |
| Historical Sortino (5Y) | -0.8662 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 36.91% |